Milrinone

• Description :

  Milrinone is a PDE3 inhibitor, and also an inotrope and vasodilator.

• Product Name Alternative :

  Win 47203

• UNSPSC :

  12352005

• Hazard Statement :

  H317, H319

• Target :

  Phosphodiesterase (PDE)

• Type :

  Reference compound

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Cardiovascular Disease

• Assay Protocol :

  https://www.medchemexpress.com/Milrinone.html

• Purity :

  99.86

• Solubility :

  DMSO : 50 mg/mL (ultrasonic)

• Smiles :

  CC(N1)=C(C2=CC=NC=C2)C=C(C#N)C1=O

• Molecular Formula :

  C12H9N3O

• Molecular Weight :

  211.22

• Precautions :

  H317, H319

• References & Citations :

  [1]Santhosh KT, et al. Milrinone attenuates thromboxane receptor-mediated hyperresponsiveness in hypoxic pulmonary arterial myocytes. Br J Pharmacol. 2011 Jul;163 (6) :1223-36.|[2]Hentschel T, et al. Inhalation of the phosphodiesterase-3 inhibitor milrinone attenuates pulmonary hypertension in a rat model of congestive heart failure. Anesthesiology. 2007 Jan;106 (1) :124-31.|[3]Kishi T, et al. Effects of milrinone on left ventricular end-systolic pressure-volume relationship of rat hearts in situ. Clin Exp Pharmacol Physiol. 2001 Sep;28 (9) :737-42.|[4]Taylor MS, et al. Effect of milrinone on small mesenteric artery vasoconstriction: role of K (+) channels. Am J Physiol. 1999 Jul;277 (1 Pt 1) :G69-78.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  Launched

• Isoform :

  PDE3

• CAS Number :

  [78415-72-2]